3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
13
Phase 2
6
Phase 3
3
Phase EARLY_PHASE1
1
Phase 1/2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
5
Gastrointestinal
3
Sarcoma
2
Other hematologic neoplasm
2
Gynecologic
2
Thoracic
1
Other solid neoplasm
1
CNS
1
Breast
1
Conditions
Stomach Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Pelvic Neoplasms
1
Ovarian Neoplasms
1
Mesothelioma, Malignant
1
Liposarcoma
1
Fallopian Tube Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Colonic Neoplasms
1
Interventions
Cyclophosphamide
5
fludarabine
4
Specimen Handling
3
alpha-Synuclein
2
Magnetic Resonance Spectroscopy
2
Interleukin-2
2
theanine
1
temsirolimus
1
spartalizumab
1
sodium thiosulfate
1
selicrelumab
1
perflutren
1
malic acid
1
amatuximab
1
X-Rays
1
Valproic Acid
1
Topotecan
1
Surgical Procedures, Operative
1
Sunitinib
1
Sulfur Hexafluoride
1
Sirolimus
1
Resistant Starch
1
Radiotherapy
1
Radiation
1
Platinum
1
Paclitaxel
1
Liquid Biopsy
1
KD025
1
Interviews as Topic
1
Indocyanine Green
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Doxorubicin
×
Other solid neoplasm
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled